Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Feb 16, 2019
Product Development

ADCs’ inflection point

How fit-for-purpose ADCs could open the modality’s floodgates
BioCentury | Oct 4, 2018
Distillery Therapeutics

Cancer

BioCentury | May 15, 2018
Distillery Techniques

Assays and screens

BioCentury | Feb 2, 2017
Distillery Therapeutics

Infectious disease

BioCentury | Nov 12, 2015
Product R&D

Probodies, anticancer

How CytomX's Probodies improve safety across immuno-oncology modalities
BioCentury | Mar 11, 2010
Distillery Therapeutics

Indication: Cancer

Items per page:
1 - 10 of 10